Induction Healthcare Group PLC Publication of Circular (5374N)
May 20 2020 - 12:06PM
UK Regulatory
TIDMINHC
RNS Number : 5374N
Induction Healthcare Group PLC
20 May 2020
20 May 2020
Induction Healthcare Group PLC
("Induction", the "Company" or the "Group")
Publication of Circular
Induction, a leading healthcare technology company that helps
healthcare professionals deliver better care more efficiently,
announces that, further to the Company's announcement yesterday in
relation to the proposed acquisition of Zesty Limited ("Zesty"), a
shareholder circular relating to the transaction (the "Circular")
has now been posted to the Company's shareholders. The Circular
contains further details on the proposed transaction and the Notice
of General Meeting.
Availability of the Circular
A copy of the Circular is now available for inspection on the
Company's website (www.InductionHealthcare.com). Further copies of
the Circular can be made available by contacting the Company
Secretary up until and including the date of the General Meeting of
the Company.
Notice of General meeting
The issue of the New Ordinary Shares (and therefore completion
of the Acquisition) is conditional upon the approval by the
Company's Shareholders of the shareholder resolutions to be
proposed at the general meeting of the Company, which is being held
at Glebe Cottage, Sandhutton, Thirsk YO7 4RW at 9.00 a.m. BST on 5
June 2020.
ENQUIRIES
Induction Healthcare
Dr Hugo Stephenson, Chief Executive Officer Via FTI Consulting
Ibs Mahmood, Chief Business Officer
Numis Securities (Nominated Adviser and
Broker) +44 (0) 207 260 1000
James Black / Freddie Barnfield / Huw Jeremy
/ Matthew Jones
FTI Consulting +44 (0) 203 727 1000
Jamie Ricketts / Elena Kalinskaya / Sam
Purewal / Mary Whittow
About Induction
Induction Healthcare Group PLC is a leading healthcare
technology company that helps healthcare professionals deliver
better care more efficiently. T he Group has two platforms,
Induction and MicroGuide, that support healthcare professionals in
multiple markets, including UK, Ireland, Australia and South
Africa. Induction is the number one healthcare collaboration app in
the UK. The app helps over 140,000 users - mostly doctors - to
increase productivity and enhance communication by securely sharing
phone numbers and bleeps, bookmarks, documents and messages in a
clinical setting. The MicroGuide platform provides medical
organisations with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. The Induction app is used by the
majority of hospital doctors within the NHS. The MicroGuide
platform is used by the majority of trusts within the NHS.
As at 1 May 2020, the Induction app had 140,819 registered
users, primarily in the UK. The registered user base grew by 67.2%
from 1 May 2019 to 1 May 2020.
As at 1 May 2020, the MicroGuide app had 173,196 registered
users, primarily in the UK. The registered user base grew by 36.2%
from 1 May 2019 to 1 May 2020.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
CIRSEEFMSESSESI
(END) Dow Jones Newswires
May 20, 2020 12:06 ET (16:06 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024